Titan Pharmaceuticals (NASDAQ:TTNP) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research note published on Monday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Stock Performance Shares of TTNP opened at $0.33 on Monday. Titan Pharmaceuticals has a fifty-two week low of $0.25 and a […]

Related Keywords

United States ,Canada , ,Millennium Management ,Titan Pharmaceuticals Inc ,Titan Pharmaceuticals Company Profile ,Renaissance Technologies ,Titan Pharmaceuticals Stock Performance ,European Union ,Virtu Financial ,Titan Pharmaceuticals ,News Ratings For Titan Pharmaceuticals Daily ,Free Report ,Get Free Report ,Street Corp ,Titan Pharmaceuticals Daily ,Nasdaq Ttnp ,Ttnp ,Medical ,Initiated Coverage ,Stocknews Com ,